Navigation Search

SALIENTVALUE


3 Things I Wish I Knew Before I Sold My I/DD Company

by Rachel Boynton, CMAA Volume 5 Issue 23, November 6, 2018 Like many owners of I/DD companies, LifeShare, the company that I co-founded with my husband and grew for over 20 years, was a true labor of love. We started our company because of a significant gap in services in New England, as well as…

READ MORE

7 Reasons Why Some Healthcare Businesses Don’t Sell (At First)

by Bradley Smith, ATP, CMAA and Tom Schramski, PhD, CMAA Volume 5 Issue 22, October 23, 2018 With over 60 combined years’ experience in the healthcare marketplace, we have seen many successes and some failures when representing healthcare owners who could not initially sell their businesses. In these latter examples they learned a hard lesson…

READ MORE


What’s The Value Of Your Independent Pharmacy (Part 2)?

by Alan J. Hymowitz and David E. Coit, Jr., DBA, CVA, CVGA, CMAA Volume 5 Issue 20, September 25, 2018 As we indicated in our recent article, “What’s The Value Of Your Independent Pharmacy (Part 1)?,” the market for independent pharmacies continues a very dynamic run. Private equity, strategic consolidators, and other investors are looking to add scale…

READ MORE

What’s The Value Of Your Independent Pharmacy (Part I)?

by David E. Coit, Jr., DBA, CVA, CVGA, CMAA, and Alan J. Hymowitz Volume 5 Issue 19, September 11, 2018 Today, there are over 22,000 independent pharmacies out of a total of over 61,000 pharmacies nationwide. In addition, independent pharmacies drive over $73 billion of industry revenue with all signs pointing to continued growth. Customer demand is…

READ MORE

There Are No Unrealistic Expectations

by Tom Schramski, PhD, CMAA Volume 5 Issue 18, August 28, 2018  There is an unfortunate term in the world of healthcare M+A intermediaries when they discuss a difficult, or even disastrous, transaction attempt: the “unrealistic expectations” of a potential seller. It is not uncommon for advisors to blame a failure on the seller’s resistance to…

READ MORE

Why It’s Critical To Know The Value(s) Of Your DME Company

by David E. Coit, Jr., DBA, CVA, CVGA, CMAA Volume 5 Issue 17, August 14, 2018  Most owners of Durable Medical Equipment (DME) companies regularly attempt to estimate the value of their company. Unfortunately, their estimates can significantly differ from the marketplace “reality,” depending on a number of factors. “All healthcare related companies sell for 2…

READ MORE

5 Provider Strategies For Confronting The End Of I/DD Carve-Outs As We Know Them

by Rachel Boynton Volume 5 Issue 16, July 31, 2018  There is no faster evolving healthcare area than the Medicaid-funded Long Term Care Support Services (LTSS) marketplace. The combination of reimbursement pressure, limited state budgets, and the movement to bring LTSS services under the direct administration of health plans (“carve ins”) is challenging many traditional I/DD…

READ MORE

5 Big Challenges (And Opportunities) In Today’s Independent Pharmacy Marketplace

by Alan J. Hymowitz Volume 5 Issue 15, July 17, 2018  The independent pharmacy marketplace has become one of the most competitive in all of healthcare. Despite the presence of CVS, Walgreen’s and RiteAid on nearly every street corner in America, independent pharmacies are beginning to increase in number. They vary from compounding pharmacies that serve…

READ MORE

6 Ways To “Look Under The Hood” And Build Value In Your SUD Company

by David E. Coit, Jr., DBA, CVA, CVGA, CMAA Volume 5 Issue 13, June 19, 2018  The Substance Use Disorder (SUD) marketplace is dynamic and continues to be impacted by many factors. The valuation of SUD programs is also subject to change, ranging from in-network vs. out-of-network reimbursement and in-house labs to the increasing focus on…

READ MORE